The Patient-2 tumor sample yielded 453 total cells, with 208 (46%) identified as HGSOC cells, from which we identified 16 different malignant cell enriched fusion transcripts (Supplementary Table S5), including the earlier-identified IGF2BP2::TESPA1 fusion between chr3 and chr12 evident in 176/208 (85%) of the tumor cells. Here, IGF2BP2 is linked to neoplasm.